Pregnancy is often a time of sweet anticipation. But the ongoing pressure to make the right decisions for the health...
Read moreThe FDA recently received requests to approve a second COVID booster. At the same, it is unsealing documents that were...
Read moreIt spreads efficiently and quickly, it generally causes milder disease than previous variants and it may confer strong protection against...
Read moreWe obsess over clinical efficiency, to where the strategy of healthcare has taken over the art of medicine. But the...
Read moreResearchers are discovering that “springing ahead” each March is connected with serious negative health effects.
Read moreResearchers have been steadily gathering important insights into the effects of COVID-19 on the body and brain. Two years into...
Read moreMisinformation abounds in healthcare, as we saw during the pandemic. This is not a problem in healthcare, but a feature...
Read morePeople typically think of food as calories, energy and sustenance. However, the latest evidence suggests that food also “talks” to...
Read moreObesity is notoriously difficult to treat. We introduce food logs and recommend diet and exercise, with varying results. Instead, we...
Read moreAlthough the medical establishment is now recognizing that sex is not binary, society as a whole has been slow to...
Read moreClinical studies have a way of reaching conclusions that do not reflect individual patient experiences. One such study concludes that...
Read moreWe have found that FDA drug warnings can sometimes prevent life-threatening adverse effects, but that unintended consequences are common.
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy